☆ 4.4 Letter

Children with sickle cell anemia and APOL1 genetic variants develop albuminuria early in life

HAEMATOLOGICA (2019)

期刊

HAEMATOLOGICA

卷 104, 期 9, 页码 -

出版社

FERRATA STORTI FOUNDATION

DOI: 10.3324/haematol.2018.212779

关键词

-

类别

Hematology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Hematology

Generalization of a genetic risk score for time to first albuminuria in children with sickle cell anaemia: SCCRIP cohort study results

Sara R. Rashkin, Evadnie Rampersaud, Guolian Kang, Kenneth I. Ataga, Jane S. Hankins, Winfred Wang, Jeremie H. Estepp, Mitchell J. Weiss, Jeffrey Lebensburger, Rima S. Zahr

Summary: Albuminuria can predict kidney disease progression in individuals with SCA, but introducing reno-protective therapies before the onset of albuminuria may attenuate disease progression. A genetic risk score (GRS) for SCA-related nephropathy may provide an improved one-time test for early identification of high-risk patients. Utilizing a GRS from a recent large trans-ethnic meta-analysis, three single nucleotide polymorphisms were identified to be associated with time to first albuminuria episode in children with SCA.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

添加到收藏夹

Article Pediatrics

Regulatory T-cell phenotypes in children with sickle cell disease

Asmaa M. Zahran, Khaled Saad, Khalid Elsayh, Shaimaa M. Khalaf, Khaled Hashim Mahmoud, Amira Elhoufey, Helal F. Hetta

Summary: Among children with SCD, HU treatment exhibited significant qualitative and quantitative effects on Tregs. HU treatment in SCD decreases the frequency of Tregs, as well as the levels of the most suppressive Tregs: HLA-DR+, CD39+, and CD69+. At the same time, HU increases the proportion of naive CD45RA+ Tregs. Our study showed the impact of HU therapy on Tregs in children with SCD.

PEDIATRIC RESEARCH (2022)

添加到收藏夹

Article Hematology

Risk factors for CKD stage II onset in a prospective cohort of homozygous sickle cell adults

Camille Roger, Francois Lionnet, Sarah Mattioni, Marine Livrozet, Olivier Steichen, Emmanuel Letavernier, Nadjib Hammoudi, Virginie Avellino, Jean-Philippe Haymann

Summary: The prevalence of renal impairment is increasing with aging in sickle cell anemia (SCA) patients, leading to high morbidity and mortality. This study identified risk factors for CKD stage II in a cohort of SCA patients, showing a strong increase in risk after 30 years old. Baseline diastolic blood pressure, macroalbuminuria, and increased LDH were independent risk factors identified, highlighting the importance of optimal blood pressure targets for SCA patients.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Genetic modulation of anemia severity, hemolysis level, and hospitalization rate in Angolan children with Sickle Cell Anemia

Isabel Germano, Brigida Santos, Mariana Delgadinho, Catarina Ginete, Pedro Lopes, Ana Paula Arez, Miguel Brito, Paula Faustino

Summary: This study investigates the genetic modulators of anemia severity, chronic hemolytic rate, and clinical manifestations in pediatric SCA patients from Angola, highlighting the importance of genetic modifiers of vascular cell adhesion and nitric oxide metabolism in SCA pediatric phenotypic variability in the Angolan population.

MOLECULAR BIOLOGY REPORTS (2022)

添加到收藏夹

Article Immunology

APOL1 risk variants in individuals of African genetic ancestry drive endothelial cell defects that exacerbate sepsis

Junnan Wu, Ziyuan Ma, Archana Raman, Pazit Beckerman, Poonam Dhillon, Dhanunjay Mukhi, Matthew Palmer, Hua Chang Chen, Cassiane Robinson Cohen, Thomas Dunn, John Reilly, Nuala Meyer, Michael Shahaty, Zoltan Arany, Gyorgy Hasko, Krzysztof Laudanski, Adriana Hung, Katalin Susztak

Summary: The incidence and severity of sepsis is higher among individuals of African versus European ancestry, with genetic risk variants in APOL1 associated with increased sepsis incidence and severity. APOL1 levels correlated with sepsis and COVID-19 severity, and targeting the inflammasome and STING pathways may help reduce APOL1-associated endothelial changes in sepsis.

IMMUNITY (2021)

添加到收藏夹

Article Oncology

Trends in quality of care among children with sickle cell anemia

Sarah L. Reeves, Gary L. Freed, Brian Madden, Meng Wu, Lauren Miller, Lindsay Cogan, David Anders, Susan E. Creary, Julie McCormick, Kevin J. Dombkowski

Summary: The study assessed trends in antibiotic prophylaxis and transcranial Doppler (TCD) screening among children with sickle cell anemia (SCA) in Michigan and New York State. Results showed that most children did not receive recommended preventive measures and there was a decrease in antibiotic prophylaxis prescription fills in NYS. Coordination of interventions across preventive services is urgently needed to improve care for children with SCA.

PEDIATRIC BLOOD & CANCER (2022)

添加到收藏夹

Article Oncology

Comparative Analysis of the APOL1 Variants in the Genetic Landscape of Renal Carcinoma Cells

Maty Tzukerman, Yeela Shamai, Ifat Abramovich, Eyal Gottlieb, Sara Selig, Karl Skorecki

Summary: The APOL1 gene risk variants are associated with increased risk of kidney disease and renal cell carcinoma in individuals of African ancestry. Using gene editing technology, researchers have demonstrated that APOL1 risk variants have significant effects on the proliferation, mitochondrial morphology, cell metabolism, and tumorigenic potential of renal cell carcinoma cells. These findings highlight the significant role of APOL1 in the pathogenesis of renal cell carcinoma and provide motivations for further studies.

CANCERS (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Are Genetic Modifiers the Answer to Different Responses to Hydroxyurea Treatment?-A Pharmacogenetic Study in Sickle Cell Anemia Angolan Children

Catarina Ginete, Mariana Delgadinho, Brigida Santos, Vera Pinto, Carina Silva, Armandina Miranda, Miguel Brito

Summary: Sickle cell anemia is a common inherited disease in sub-Saharan Africa with heterogeneous phenotypes. Hydroxyurea is the main treatment for these patients, but response to treatment varies. Identifying genetic variants associated with hydroxyurea response is important for predicting treatment outcomes. A pharmacogenetic study in Angolan children identified 30 variants in 18 genes that may be associated with drug response and found associations with hematological, biochemical, and clinical parameters. Further research is needed to confirm these findings.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Article Medicine, Research & Experimental

Novel kidney injury biomarkers in a large cohort of children with sickle cell anemia

Andre R. Belisario, Roberta da Filha, Jessica A. de Almeida, Fabiola G. Mendes, Paulo Rezende, Erica L. M. Vieira, Ana C. S. Silva

Summary: This study aimed to compare novel kidney injury biomarkers in children with Sickle Cell Anemia, and found that certain markers were associated with albuminuria and glomerular hyperfiltration. The results suggest potential structural and functional abnormalities in these children.

BIOMARKERS IN MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Parent-reported sleep problems in children and adolescents with sickle cell disease: relationship to health-related quality of life

Serkan Gunes, Rahime Aldemir, Adem Gunes, Ozalp Ekinci

Summary: There is a negative relationship between sleep problems and health-related quality of life (HRQOL) in children and adolescents with sickle cell disease (SCD). Disease severity and sleep problems may predict the overall HRQOL in this population.

ARCHIVES OF MEDICAL SCIENCE (2022)

添加到收藏夹

Article Environmental Sciences

Associations between APOL1 genetic variants and blood pressure in African American mothers and children from a US pregnancy cohort: Modification by air pollution exposures

Yu Ni, Claire L. Simpson, Robert L. Davis, Adam A. Szpiro, Catherine J. Karr, Csaba P. Kovesdy, Rebecca C. Hjorten, Frances A. Tylavsky, Nicole R. Bush, Kaja Z. LeWinn, Cheryl A. Winkler, Jeffrey B. Kopp, Yoshitsugu Obi

Summary: This study found that the presence of high-risk APOL1 genetic variants is not directly associated with blood pressure levels. However, in mothers with the high-risk genotype, air pollution has a greater impact on blood pressure. Additionally, the effects of APOL1 genetic variants and the high-risk genotype on high blood pressure are stronger in girls.

ENVIRONMENTAL RESEARCH (2022)

添加到收藏夹

Article Hematology

APOL1 Genetic Variants Are Associated With Increased Risk of Coronary Atherosclerotic Plaque Rupture in the Black Population

Anne Cornelissen, Daniela T. Fuller, Raquel Fernandez, Xiaoqing Zhao, Robert Kutys, Elizabeth Binns-Roemer, Marco Delsante, Atsushi Sakamoto, Ka Hyun Paek, Yu Sato, Rika Kawakami, Masayuki Mori, Kenji Kawai, Teruhiko Yoshida, Khun Zaw Latt, Clint L. Miller, Paul S. de Vries, Frank D. Kolodgie, Renu Virmani, Myung Kyun Shin, Maarten Hoek, Jurgen Heymann, Jeffrey B. Kopp, Avi Z. Rosenberg, Harry R. Davis, Liang Guo, Aloke V. Finn

Summary: The study found that APOL1 risk alleles are associated with coronary artery disease, with carriers being more prone to thrombotic events. Individuals with 2 APOL1 risk alleles have larger necrotic cores in plaques, suggesting a role of APOL1 in determining plaque stability.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

From Stress to Sick(le) and Back Again-Oxidative/Antioxidant Mechanisms, Genetic Modulation, and Cerebrovascular Disease in Children with Sickle Cell Anemia

Marisa Silva, Paula Faustino

Summary: Sickle cell anemia is a genetic disease with complex pathophysiological mechanisms that are modulated by both environmental and genetic factors. Pediatric cerebrovascular disease is one of the most impactful manifestations of this disease. Oxidative stress plays a crucial role in the pathophysiology, and the genetic modulation of the disease is also discussed.

ANTIOXIDANTS (2023)

添加到收藏夹

Article Urology & Nephrology

APOL1 Renal Risk Variants and Sickle Cell Trait Associations With Reduced Kidney Function in a Large Congolese Population-Based Study

Mannix Imani Masimango, Michel Jadoul, Elizabeth A. Binns-Roemer, Victor A. David, Ernest Kiswaya Sumaili, Cheryl A. Winkler, Sophie Limou

Summary: APOL1, GSTM1 risk variants, and sickle cell trait (SCT) are associated with chronic kidney disease (CKD) among African Americans (AAs), but there is scarce evidence in sub-Saharan Africa (SSA) populations. Our study highlights the impact of APOL1 and SCT variants on poorer renal outcomes in the Democratic Republic of Congo (DRC) and advocates for further genetic studies in SSA.

KIDNEY INTERNATIONAL REPORTS (2022)

添加到收藏夹

Article Hematology

Early diagnosis of sickle cell disease at birth hospitals and vaccination centers in Angola using point-of-care tests

Halimat S. Olaniyan, Christine Briscoe, Margarida Muhongo, Rui Pascoal, Antonio Armando, Brigida Santos, Patrick T. McGann

Summary: This study evaluated and compared two point-of-care (POC) tests for sickle cell disease (SCD) screening in infants in Luanda, Angola. The results demonstrated high diagnostic accuracy for both tests, and the inclusion of vaccination centers may improve the capture rate for early infant SCD screening programs.

BLOOD ADVANCES (2023)

添加到收藏夹

Article Oncology

Genomic profiling identifies genes and pathways dysregulated by HEY1-NCOA2 fusion and shines a light on mesenchymal chondrosarcoma tumorigenesis

Wenqing Qi, Wojciech Rosikiewicz, Zhaohong Yin, Beisi Xu, Huihong Jiang, Shibiao Wan, Yiping Fan, Gang Wu, Lu Wang

Summary: Mesenchymal chondrosarcoma is a rare and aggressive primitive mesenchymal tumor that mainly affects adolescents and young adults. Researchers have identified the fusion protein HEY1-NCOA2, which promotes cell proliferation and upregulates the expression of PDGFB and PDGFRA, providing a potential target for treating mesenchymal chondrosarcoma.

JOURNAL OF PATHOLOGY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

A rare variant analysis framework using public genotype summary counts to prioritize disease-predisposition genes

Wenan Chen, Shuoguo Wang, Saima Sultana Tithi, David W. Ellison, Daniel J. Schaid, Gang Wu

Summary: This article introduces a framework that can control confounding factors in clinical and cancer genomics studies to identify genes enriched with pathogenic variants. By controlling genotype summary counts from public data sets, this framework provides a cost-effective solution for prioritizing disease-risk genes enriched with rare pathogenic variants.

NATURE COMMUNICATIONS (2022)

添加到收藏夹

Article Pathology

Sequential Approach to Improve the Molecular Classification of Childhood Acute Lymphoblastic Leukemia

Chih-Hsiang Yu, Gang Wu, Chia-Ching Chang, Shiann-Tarng Jou, Meng-Yao Lu, Kai-Hsin Lin, Shu-Huey Chen, Kang-Hsi Wu, Chao-Neng Cheng, Fang-Liang Huang, Chao-Neng CHeng, Hsiu-Hao Chang, Dale Hedges, Jinn-Li Wang, Hsiu-Ju Yen, Meng-Ju Li, Shu-Wei Chou, Chen-Ting Hung, Ze-Shiang Lin, Chien-Yu Lin, Hsuan-Yu Chen, Yu-Ling Ni, Yin-Chen Hsu, Dong-Tsamn Lin, Shu-Wha Lin, Jun J. Yang, Ching-Hon Pui, Sung-Liang Yu, Yung-Li Yang

Summary: Identification of specific leukemia subtypes is crucial for risk-directed therapy in childhood acute lymphoblastic leukemia (ALL). Although RNA sequencing (RNA-seq) is the most effective method, its routine use is expensive in resource-limited countries. This study enrolled 295 pediatric ALL patients and used a combination of screening methods and RNA-seq to improve classification and clinical assessment of childhood ALL.

JOURNAL OF MOLECULAR DIAGNOSTICS (2022)

添加到收藏夹

Article Oncology

Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma

Allison Pribnow, Barbara Jonchere, Jingjing Liu, Kyle S. Smith, Olivia Campagne, Ke Xu, Sarah Robinson, Yogesh Patel, Arzu Onar-Thomas, Gang Wu, Clinton F. Stewart, Paul A. Northcott, Jiyang Yu, Giles W. Robinson, Martine F. Roussel

Summary: Combining ribociclib and gemcitabine can effectively slow down tumor progression and metastasis, and improve survival in patients with G3MB. Molecular analysis reveals significant changes in gene activity and expression, which may be related to cell cycle progression, DNA damage response, and neuronal differentiation. This study suggests that the combination therapy of ribociclib and gemcitabine is a promising treatment strategy for children with G3MB and deserves further investigation.

MOLECULAR CANCER THERAPEUTICS (2022)

添加到收藏夹

Article Hematology

Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma

Jamie E. Flerlage, Jason R. Myers, Jamie L. Maciaszek, Ninad Oak, Sara R. Rashkin, Yawei Hui, Yong-Dong Wang, Wenan Chen, Gang Wu, Ti-Cheng Chang, Kayla Hamilton, Saima S. Tithi, Lynn R. Goldin, Melissa Rotunno, Neil Caporaso, Aurelie Vogt, Deborah Flamish, Kathleen Wyatt, Jia Liu, Margaret Tucker, Christopher N. Hahn, Anna L. Brown, Hamish S. Scott, Charles Mullighan, Kim E. Nichols, Monika L. Metzger, Mary L. McMaster, Jun J. Yang, Evadnie Rampersaud

Summary: Familial aggregation of HL has been shown to have a genetic component. In this study, whole genome sequencing was performed on individuals with and without HL from pedigrees with multiple affected relatives. A total of 44 HL-risk variants were identified, including both coding and noncoding variants. The study also identified several novel variants and observed segregation patterns in most pedigrees.

BLOOD (2023)

添加到收藏夹

Article Oncology

Clinical impact of minimal residual disease and genetic subtypes on the prognosis of childhood acute lymphoblastic leukemia

Chih-Hsiang Yu, Shiann-Tarng Jou, Ying-Hui Su, Elane Coustan-Smith, Gang Wu, Chao-Neng Cheng, Meng-Yao Lu, Kai-Hsin Lin, Kang-Hsi Wu, Shu-Huey Chen, Fang-Liang Huang, Hsiu-Hao Chang, Jinn-Li Wang, Hsiu-Ju Yen, Meng-Ju Li, Shu-Wei Chou, Wan-Ling Ho, Yen-Lin Liu, Chia-Ching Chang, Ze-Shiang Lin, Chien-Yu Lin, Hsuan-Yu Chen, Yu-Ling Ni, Dong-Tsamn Lin, Shu-Wha Lin, Jun J. Yang, Yen-Hsuan Ni, Ching-Hon Pui, Sung-Liang Yu, Yung-Li Yang

Summary: This study analyzed data from two consecutive protocols to determine the clinical impact of minimal/measurable residual disease (MRD) and tumor genetic subtypes in newly diagnosed pediatric acute lymphoblastic leukemia (ALL) patients. The results showed that MRD-directed therapy improved outcomes for pediatric ALL, especially for standard-risk patients. This study provides important data to inform the design of future clinical trials in Taiwan.

CANCER (2023)

添加到收藏夹

Article Oncology

Malignant Progression of an Ancestral Bone Marrow Clone Harboring a CIC-NUTM2A Fusion in Isolated Myeloid Sarcoma

Jennifer L. Kamens, Jinjun Dang, Timothy I. Shaw, Alexander M. Gout, Scott Newman, Kohei Hagiwara, Amelia M. R. Smith, Alyssa N. Obermayer, Sarah Aldridge, Jing Ma, Yang Zhang, Gang Wu, Vasiliki Leventaki, Teresa Santiago, Susana Raimondi, Joy Nakitandwe, Alberto Pappo, Chunliang Li, Jinghui Zhang, Tanja A. Gruber

Summary: This study reports a case of myeloid sarcoma with fusion oncogene CIC-NUTM2A, suggesting its clonal evolution from bone marrow despite the absence of pathology. Murine modeling confirmed the transforming ability of the fusion gene and identified RTK signaling activation. These findings broaden the definition of CIC-rearranged malignancies and emphasize the importance of molecular analysis and tracking bone marrow involvement in myeloid sarcoma.

MOLECULAR CANCER RESEARCH (2023)

添加到收藏夹

Letter Hematology

Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemia

Carolin Escherich, Wenan Chen, Satoshi Miyamoto, Yui Namikawa, Wenjian Yang, David T. Teachey, Zhenhua Li, Elizabeth A. Raetz, Eric Larsen, Meenakshi Devidas, Paul L. Martin, Gang Wu, Ching-Hon Pui, Stephen P. Hunger, Mignon L. Loh, Masatoshi Takagi, Jun J. Yang

BLOOD ADVANCES (2023)

添加到收藏夹

Article Hematology

The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21

Qingsong Gao, Sarra L. Ryan, Ilaria Iacobucci, Pankaj S. Ghate, Ruth E. Cranston, Claire Schwab, Abdelrahman H. Elsayed, Lei Shi, Stanley Pounds, Shaohua Lei, Pradyuamna Baviskar, Deqing Pei, Cheng Cheng, Matthew Bashton, Paul Sinclair, David R. Bentley, Mark T. Ross, Zoya Kingsbury, Terena James, Kathryn G. Roberts, Meenakshi Devidas, Yiping Fan, Wenan Chen, Ti-Cheng Chang, Gang Wu, Andrew Carroll, Nyla Heerema, Virginia Valentine, Marcus Valentine, Wenjian Yang, Jun J. Yang, Anthony Moorman, Christine J. Harrison, Charles G. Mullighan

Summary: In this study, the genomic and transcriptomic profiles of 124 patients with iAMP21-ALL were analyzed, revealing subgroups based on copy number alteration and structural variation. The study identified a common amplification region on chromosome 21 and found several differentially expressed genes associated with acute leukemia. Single-cell genomic profiling showed clonal heterogeneity and genomic evolution, indicating that the acquisition of iAMP21 is an early event that may progress during disease development. The study also found characteristic secondary genetic features and suggested the use of cytogenetic or genomic methods for precise diagnosis of iAMP21-ALL.

BLOOD (2023)

添加到收藏夹

Article Hematology

Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia

Zhenhua Li, Ti-Cheng Chang, Jacob J. Junco, Meenakshi Devidas, Yizhen Li, Wenjian Yang, Xin Huang, Dale J. Hedges, Zhongshan Cheng, Mary Shago, Andrew J. Carroll, Nyla A. Heerema, Julie Gastier-Foster, Brent L. Wood, Michael J. Borowitz, Lauren Sanclemente, Elizabeth A. Raetz, Stephen P. Hunger, Eleanor Feingold, Tracie C. Rosser, Stephanie L. Sherman, Mignon L. Loh, Charles G. Mullighan, Jiyang Yu, Gang Wu, Philip J. Lupo, Karen R. Rabin, Jun J. Yang

Summary: This study investigates the genomics of Down syndrome-related acute lymphoblastic leukemia (DS-ALL) and identifies 15 molecular subtypes, as well as abnormal activation of key genes. It also reveals the common occurrence of somatic genomic abnormalities mediated by gene rearrangements in DS-ALL and the association between subtype heterogeneity and prognosis. These findings provide important insights into the biology of DS-ALL and offer opportunities for individualized treatment.

BLOOD (2023)

添加到收藏夹

Article Oncology

ATM inhibition enhances the efficacy of radiation across distinct molecular subgroups of pediatric high-grade glioma

Jia Xie, Teneema Kuriakose, Brandon Bianski, Nathaniel Twarog, Evan Savage, Ke Xu, Xiaoyan Zhu, Chen He, Baranda Hansen, Hong Wang, Anthony High, Yuxin Li, Jerold E. Rehg, Heather S. Tillman, Burgess B. Freeman, Zoran Rankovic, Arzu Onar-Thomas, Yiping Fan, Gang Wu, Junmin Peng, Shondra Miller, Suzanne J. Baker, Anang A. Shelat, Christopher L. Tinkle

Summary: This study aimed to evaluate the therapeutic potential and molecular consequences of combining radiation with selective DDR inhibition in pediatric high-grade glioma (pHGG). The results showed that the ATM inhibitor AZD1390 significantly potentiated radiation in pHGG, regardless of TP53 status. Additionally, a novel mechanism of resistance to AZD1390 + radiation was identified, which involved attenuated ATM pathway response and synthetic lethality with ATR inhibition.

NEURO-ONCOLOGY (2023)

添加到收藏夹

Article Multidisciplinary Sciences

Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication

Yanling Liu, Jonathon Klein, Richa Bajpai, Li Dong, Quang Tran, Pandurang Kolekar, Jenny L. Smith, Rhonda E. Ries, Benjamin J. Huang, Yi-Cheng Wang, Todd A. Alonzo, Liqing Tian, Heather L. Mulder, Timothy I. Shaw, Jing Ma, Michael P. Walsh, Guangchun Song, Tamara Westover, Robert J. Autry, Alexander M. Gout, David A. Wheeler, Shibiao Wan, Gang Wu, Jun J. Yang, William E. Evans, Mignon Loh, John Easton, Jinghui Zhang, Jeffery M. Klco, Soheil Meshinchi, Patrick A. Brown, Shondra M. Pruett-Miller, Xiaotu Ma

Summary: The authors identified 272 oncogenic fusions in childhood cancer patients and explored their etiologies, links with tumor progression, and therapeutic potential. These findings have important clinical implications, such as risk stratification and genome-editing-based therapeutics.

NATURE COMMUNICATIONS (2023)

添加到收藏夹

Article Clinical Neurology

Temporal course of cognitive and behavioural changes in motor neuron diseases

Caroline A. McHutchison, Joanne Wuu, Corey T. McMillan, Rosa Rademakers, Jeffrey Statland, Gang Wu, Evadnie Rampersaud, Jason Myers, Jessica P. Hernandez, Sharon Abrahams, Michael Benatar, CReATe Consortium

Summary: In this study, researchers explored the cognitive and behavioral changes in people with motor neuron disease (MND) over time. They found that cognitive impairment was less common than previously reported and remained stable for most participants. However, a small subset of participants experienced a decline in cognition over time, which was not solely related to the C9ORF72 genetic mutation. These findings raise questions about the timing and progression of cognitive impairment in MND.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)

添加到收藏夹

Article Multidisciplinary Sciences

SNIP1 and PRC2 coordinate cell fates of neural progenitors during brain development

Yurika Matsui, Mohamed Nadhir Djekidel, Katherine Lindsay, Parimal Samir, Nina Connolly, Gang Wu, Xiaoyang Yang, Yiping Fan, Beisi Xu, Jamy C. Peng

Summary: The study shows that SNIP1 is critical for the survival and differentiation of stem cells in the developing brain. It regulates PRC2 activities downstream of TGFb and NFkB, influencing cell fates. Understanding the role of SNIP1 in brain development can provide insights into cell survival and death during development.

NATURE COMMUNICATIONS (2023)

添加到收藏夹

Article Oncology

Cancer germline predisposing variants and late mortality from subsequent malignant neoplasms among long-term childhood cancer survivors: a report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor Study

Cheng Chen, Na Qin, Mingjuan Wang, Qian Dong, Saima Sultana Tithi, Yawei Hui, Wenan Chen, Gang Wu, Dennis Kennetz, Michael N. Edmonson, Michael C. Rusch, Andrew Thrasher, John Easton, Heather L. Mulder, Nan Song, Noel -Marie Plonski, Kyla Shelton, Cindy Im, Matthew J. Ehrhardt, Kim E. Nichols, Wendy M. Leisenring, Kayla L. Stratton, Rebecca Howell, Yutaka Yasui, Smita Bhatia, Gregory Armstrong, Kirsten K. Ness, Melissa M. Hudson, Jinghui Zhang, Hui Wang, Deo Kumar Srivastava, Leslie L. Robison, Zhaoming Wang

Summary: Carriers of cancer predisposing variants are at an increased risk of developing subsequent malignant neoplasms among childhood cancer survivors. Implementing early personalized cancer surveillance and prevention strategies based on genetic counseling and clinical genetic testing can reduce the risk of subsequent malignant neoplasm-related mortality.

LANCET ONCOLOGY (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.